Uncover key drivers, emerging technologies, and competitive movements shaping the worker heat stress monitoring wearable market from 2026–2035 with trusted insights from The Business Research Company

What are the forecasted starting (2026) and ending (2030) market sizes for the Intranasal Drug Delivery Devices Market?

The market for intranasal drug delivery devices has experienced significant expansion over recent years. Forecasts indicate it will expand from $65.09 billion in 2025 to $70.77 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 8.7%. This historical growth is linked to factors such as the rising incidence of respiratory and nasal conditions, the growing adoption of the nasal pathway for systemic drug administration, the proliferation of self-administration drug devices, a surge in approvals for intranasal treatments, and the wider implementation of outpatient care models.

The intranasal drug delivery devices market size is anticipated to experience substantial growth in the coming years. It is projected to expand to $99.11 billion by 2030, driven by a compound annual growth rate (CAGR) of 8.8%. This growth during the forecast period can be attributed to factors such as the increasing development of biologics and vaccines through nasal delivery, the rising demand for drug administration in homecare settings, the expansion of intranasal delivery for neurological therapies, growing investments in advanced drug-device combinations, and an increasing focus on patient compliance solutions. Major trends expected in the forecast period include the increasing adoption of precision nasal delivery systems, a rising demand for non-invasive drug administration, the growing development of multi-dose nasal devices, the expansion of patient-friendly drug delivery formats, and an enhanced focus on rapid drug absorption.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13463&type=smp

What Drivers Are Supporting Technological Adoption In The Intranasal Drug Delivery Devices Market?

The growing occurrence of chronic diseases is anticipated to fuel the expansion of the intranasal drug delivery devices market. Chronic diseases are ailments characterized as conditions that persist for 1 year or more, demanding ongoing medical attention, limiting daily activities, or both. Intranasal drug delivery devices are instrumental in managing chronic diseases by offering a non-invasive and efficient means for medication administration. They facilitate the direct delivery of medications to the target area, which is convenient, straightforward to use, and promotes swift absorption. For example, in June 2024, according to the National Health Service, a UK-based government department, the number of individuals in England at risk of developing type 2 diabetes in 2023 had increased to 3,615,330, up from 3,066,330 in 2022, with an additional over half a million (549,000) people identified with non-diabetic hyperglycemia, or pre-diabetes. Consequently, the rising prevalence of chronic diseases is driving the growth of the intranasal drug delivery devices market.

What Segment Types Are Examined In The Intranasal Drug Delivery Devices Market?

The intranasal drug delivery devices market covered in this report is segmented –

1) By Product: Powder Delivery Device, Liquid Delivery Device, Pressurized Metered-Dose Inhalers, Other Products

2) By Dosage: Unit-Dose, Multi-Dose

3) By Application: Chronic Obstructive Pulmonary Disease (COPD), Rhinitis, Cystic Fibrosis, Nasal Congestion, Asthma, Other Applications

4) By End User: Hospitals, Clinics, Homecare, Other End Users

Subsegments:

1) By Powder Delivery Device: Single-Dose Powder Device, Multi-Dose Powder Device

2) By Liquid Delivery Device: Single-Dose Liquid Device, Multi-Dose Liquid Device

3) By Pressurized Metered-Dose Inhalers (pMDIs): Breath-Actuated PMDIs, Conventional pMDIs

4) By Other Products: Gel Delivery Device, Nebulizers, Nasal Sprays

What Trends Are Projected To Support The Growth Of The Intranasal Drug Delivery Devices Market?

Leading companies in the intranasal drug delivery devices market are focused on developing enhanced products, such as recyclable polyolefin nasal spray actuators, to improve sustainability, foster patient compliance, and support environmentally friendly drug delivery solutions. A recyclable polyolefin nasal spray actuator describes a nasal drug delivery component crafted solely from polyolefin materials, engineered for multi-dose administration without any metal parts. For example, in January 2023, Aptar Pharma, a US-based drug delivery and pharmaceutical solutions company, unveiled the APF Futurity, which is the first metal-free multidose nasal spray pump created to meet the rising demand for highly recyclable packaging. The APF Futurity is manufactured entirely from polyolefin materials, contains no metal components, and holds a Class AA highly recyclable certification from cyclos-HTP. This pump provides precise and consistent dosing with gentle actuation, is compatible with nasal saline and other over-the-counter formulations, and promotes sustainable recycling, positioning it as an ideal choice for environmentally conscious drug delivery solutions and patient convenience.

Who Are The Primary Competitors In The Global Intranasal Drug Delivery Devices Market?

Major companies operating in the intranasal drug delivery devices market are Johnson and Johnson Inc., Novartis AG, AstraZeneca plc., GlaxoSmithKline Plc, 3M Company, Becton Dickinson and Company, Teva Pharmaceutical Industries Ltd., AptarGroup Inc., West Pharmaceutical Services Inc., Recipharm AB, Nemera Development S.A., Consort Medical plc., Vectura Group plc., OptiNoset Inc., Flamel Technologies, Aegis Therapeutics LLC, PendoPharm Inc., Kurve Technology Inc., Impel NeuroPharma, Impexium Medical Products, ENT Technologies Pty. Ltd., Neurelis Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/intranasal-drug-delivery-devices-global-market-report

Which Regions Are Projected To Dominate The Intranasal Drug Delivery Devices Market In The Coming Years?

North America was the largest region in the intranasal drug delivery devices market in 2025. The regions covered in the intranasal drug delivery devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Intranasal Drug Delivery Devices Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=13463&type=smp

Browse Through More Reports Similar to the Global Intranasal Drug Delivery Devices Market 2026, By The Business Research Company

Nail Salon Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/nail-salon-global-market-report

Nail Polish Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/nail-polish-global-market-report

Medical Tubing Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/medical-tubing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company